C07D 237/04
Having less than three double bonds between ring members or between ring
Official title: having less than three double bonds between ring members or between ring members and non-ring members
C07D237/04 (Having less than three double bonds between ring members or between ring) appears on 270 US grants and 172 published applications in this corpus.
Search patents in C07D- Granted patents
- 270
- Published applications
- 172
- Assignees
- 142
- Inventors
- 876
- Latest grant
- 5 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 3 | 0 |
| 1978 | 4 | 0 |
| 1979 | 4 | 0 |
| 1980 | 2 | 0 |
| 1981 | 2 | 0 |
| 1982 | 4 | 0 |
| 1983 | 5 | 0 |
| 1984 | 3 | 0 |
| 1985 | 6 | 0 |
| 1986 | 7 | 0 |
| 1987 | 18 | 0 |
| 1988 | 7 | 0 |
| 1989 | 12 | 0 |
| 1990 | 11 | 0 |
| 1991 | 3 | 0 |
| 1992 | 9 | 0 |
| 1993 | 4 | 0 |
| 1994 | 1 | 0 |
| 1995 | 8 | 0 |
| 1996 | 6 | 0 |
| 1997 | 9 | 0 |
| 1998 | 10 | 0 |
| 1999 | 7 | 0 |
| 2000 | 3 | 0 |
| 2001 | 4 | 0 |
| 2002 | 7 | 5 |
| 2003 | 4 | 8 |
| 2004 | 4 | 11 |
| 2005 | 4 | 14 |
| 2006 | 10 | 8 |
| 2007 | 6 | 10 |
| 2008 | 2 | 7 |
| 2009 | 6 | 3 |
| 2010 | 0 | 4 |
| 2011 | 1 | 7 |
| 2012 | 3 | 3 |
| 2013 | 2 | 4 |
| 2014 | 3 | 7 |
| 2015 | 3 | 3 |
| 2016 | 11 | 10 |
| 2017 | 9 | 11 |
| 2018 | 8 | 8 |
| 2019 | 4 | 3 |
| 2020 | 5 | 9 |
| 2021 | 2 | 6 |
| 2022 | 6 | 7 |
| 2023 | 6 | 7 |
| 2024 | 4 | 7 |
| 2025 | 2 | 6 |
| 2026 | 5 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Pharmaceutical compositions for subcutaneous administration of levosimendan5 May 2026US 12,616,694 B2Tenax Therapeutics, Inc.
- Oxopyridazinyl-phenyl-carbonohydrazonoyl dicyanide compound and use thereof28 Apr 2026US 12,612,372 B2Korea Institute of Science and Technology
- Small molecules against cereblon to enhance effector T cell function3 Mar 2026US 12,564,583 B2Lee Moffitt Cancer Center and Research Institute, Inc.
- Herbicidal compounds3 Feb 2026US 12,540,120 B2Syngenta Crop Protection AG
- 2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer13 Jan 2026US 12,522,594 B2Deutsches Krebsforschungszentrum
- Pharmaceutical compositions for subcutaneous administration of levosimendan27 Aug 2026US 2026/0248785 A1Tenax Therapeutics, Inc.
- Compounds that participate in cooperative binding and uses thereof6 Aug 2026US 2026/0224565 A1Revolution Medicines, Inc.
- Gip receptor agonist compounds23 Apr 2026US 2026/0108546 A1Eli Lilly and Company
- 2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer9 Apr 2026US 2026/0098036 A1Deutsches Krebsforschungszentrum
- Compounds that participate in cooperative binding and uses thereof26 Jun 2025US 2025/0206715 A1Revolution Medicines, Inc.
Most cited
By later US patents
- Pyridazo[1,2-a][1,2]diazepines89US 4,512,924 AHoffmann-La Roche Inc. · 1985
- 4,5-dihydro-3(2H)-pyridazinones and their pharmacological use75US 4,816,454 ACassella Aktiengesellschaft · 1989
- Neprilysin inhibitors67US 8,586,536 B2Theravance, Inc. · 2013
- Herbicides64US 6,894,005 B1Syngenta Crop Protection AG · 2005
- Pyridazinone-substituted benzimidazoles and salts55US 4,361,563 ADr. Karl Thomae GmbH · 1982